Mouse Models of Ovarian Cancer
卵巢癌小鼠模型
基本信息
- 批准号:6944831
- 负责人:
- 金额:$ 2.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-01 至 2007-08-31
- 项目状态:已结题
- 来源:
- 关键词:cell growth regulationcell linedisease /disorder modelepitheliumfemale reproductive system neoplasmgene induction /repressiongene targetinggenetically modified animalshomeobox geneslaboratory mousemetastasismodel design /developmentneoplasm /cancer geneticsoncogenesovary neoplasmspredoctoral investigatortumor suppressor genes
项目摘要
DESCRIPTION (provided by applicant): Ovarian cancer is the leading cause of death from gynecological malignancies among females in the world. It is this fact and the lack of symptoms and reliable clinical markers in the early stages of the disease that make studying ovarian cancer so important. Several mouse models have been generated and have proven to be quite valuable in understanding the mechanisms that underlie neoplasmic transformation, progression and metastasis of various other human cancers. However, currently there are only a few mouse models of ovarian cancer available. The proposed research aims to develop a new generation of mouse models of ovarian cancer. I will establish an inducible system to delete tumor suppressor genes specifically in the surface epithelium of the ovary where human ovarian tumors are thought to arise. The generation of such a mouse model will provide insight into the genetic and molecular alterations that take place in ovarian cancer. Likewise, they will ultimately be highly beneficial to the identification of early diagnostic markers, prognostic markers, and other genetic changes that could potentially be used for human ovarian cancer studies.
描述(由申请方提供):卵巢癌是全球女性妇科恶性肿瘤的主要死亡原因。正是这一事实,以及在疾病的早期阶段缺乏症状和可靠的临床标志物,使得研究卵巢癌变得如此重要。已经产生了几种小鼠模型,并且已经证明在理解各种其他人类癌症的肿瘤转化、进展和转移的机制方面是非常有价值的。然而,目前只有少数卵巢癌小鼠模型可用。这项研究旨在开发新一代卵巢癌小鼠模型。我将建立一个可诱导的系统,删除肿瘤抑制基因,特别是在卵巢表面上皮细胞,人类卵巢肿瘤被认为是产生。这种小鼠模型的产生将提供对卵巢癌中发生的遗传和分子改变的深入了解。同样,它们最终将非常有益于鉴定早期诊断标志物、预后标志物和其他可能用于人类卵巢癌研究的遗传变化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANNA M PUZIO其他文献
ANNA M PUZIO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANNA M PUZIO', 18)}}的其他基金
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 2.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 2.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 2.92万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 2.92万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 2.92万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 2.92万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 2.92万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 2.92万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 2.92万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 2.92万 - 项目类别:
Studentship